You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Merck
Colorcon
Boehringer Ingelheim
McKesson

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 6,004,583

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,004,583
Title: Protein-containing polymer composition for oral administration
Abstract:A therapeutic-containing composition adapted for the oral administration of a biologically active material which comprises a water insoluble but water swellable polymer chemically modified with an enzyme inhibitor containing a chemical functionality which has an interactive affinity for target receptors located on the transport barrier walls of the digestive tract of the intended recipient, and at least one therapeutic of low oral bioavailability.
Inventor(s): Plate ; Nikolai A. (Moscow, RU), Valuev; Lev I. (Moscow, RU), Valueva; Tatyana A. (Moscow, RU), Staroseltseva; Ludmila K. (Moscow, RU), Ametov; Alexander S. (Moscow, RU), Knyazhev; Vladimir A. (Moscow, RU), Henis; Jay M.S. (St. Louis, MO)
Assignee: Orex Pharmaceutical Development Corp. (St. Louis, MO)
Application Number:08/691,617
Patent Claims:see list of patent claims

Details for Patent 6,004,583

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Orex Pharmaceutical Development Corp. (St. Louis, MO) 2014-03-23 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Orex Pharmaceutical Development Corp. (St. Louis, MO) 2014-03-23 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Orex Pharmaceutical Development Corp. (St. Louis, MO) 2014-03-23 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Orex Pharmaceutical Development Corp. (St. Louis, MO) 2014-03-23 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
AstraZeneca
Johnson and Johnson
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.